Guselkumab Shows Skin Clearance in Psoriasis, Joint Symptom Improvement in Psoriatic Arthritis
At AAD VMX 2021, researchers presented data on skin clearance rates through 5 years with guselkumab in patients with moderate to severe plaque psoriasis.
All articles by Brandon May
Dupilumab and Topical Corticosteroids Improve Atopic Dermatitis Symptoms
Nearly half of patients in the dupilumab arms achieved all 3 clinically meaningful endpoints in the phase 3 LIBERTY AD PEDS trial.
Patient-Reported Outcomes Best for Assessing Health Status in HFrEF
Patient-reported outcomes are a more sensitive measure than NYHA functional class for assessing changes in health status in HFrEF.
Research Highlights Emerging Novel Interventions for Neuropathic Pain
Study authors discuss recent advances in the interventional management of neuropathic pain; new therapies are needed to offer longitudinal and sustained management.
Fibromyalgia Associated With Hypersensitivity to Heat and Auditory Stimuli
Supraspinal augmentation of sensory input, including sound, may represent a hallmark of fibromyalgia.
Elevated Serum GFAP Predicts MS-Associated Diffuse White Matter Damage
Investigators sought to better understand the pathological correlates associated with increased serum GFAP in the normal appearing white matter of patients with multiple sclerosis.
Experts Warn About the Potential Implications of Azithromycin Misuse in Acne Treatment
The misuse of azithromycin in the treatment of acne is reviewed.
Treatment With Testosterone Significantly Reduces T2D Risk
Overweight or obese men frequently have low serum testosterone concentrations, which is associated with increased risk of type 2 diabetes.
Indoor Mold Exposure, Anti-Aspergillus Antibodies May Hold Clinical Implications for COPD
Indoor mold exposure and the presence of anti-Aspergillus antibodies may be linked to worsened lung function during exacerbations in COPD.
Real-World Study: Guselkumab May Be Effective for Moderate to Severe Plaque Psoriasis
Real-world data from patients with plaque psoriasis treated with guselkumab, who had previously been administered biologic agents is presented.
- Loading...
Loading...
Next post in Psoriasis Information Center
Loading... 
Loading...